Wilmington, Delaware, Feb. 16, 2025 (GLOBE NEWSWIRE) — Allied Market Research published a report, titled, “Vaccine Adjuvants Market by Type (Immunostimulants, Vehicles and Mucosal Adjuvants), Disease (Infectious Diseases, and Others), and Application (Research, and Commercial): Global Opportunity Analysis and Industry Forecast, 2024-2035″. According to the report, the “vaccine adjuvants market” was valued at $820.2 million in 2023, and is estimated to reach $1,304.83 million by 2035, growing at a CAGR of 3.9% from 2024 to 2035.
Request Sample of the Report on Global Vaccine Adjuvants Market 2035 – https://www.alliedmarketresearch.com/request-sample/1666
Prime determinants of growth
Increase in prevalence of infectious diseases, growing funding for vaccines and infectious diseases, and expansion of vaccination programs are the major factors that drive the growth of the vaccine adjuvants market. However, high initial and R&D cost for vaccine adjuvants may restrict the market growth. Moreover, growth potential in emerging markets and advancements in vaccine adjuvant research are expected to open new avenues in the coming years.
Report coverage & details:
| Report Coverage | Details |
| Forecast Period | 2024–2035 |
| Base Year | 2023 |
| Market Size in 2023 | $820.2 million |
| Market Size in 2035 | $1,304.83 million |
| CAGR | 3.9% |
| No. of Pages in Report | 339 |
| Segments covered | Type, Disease, Application, and Region |
| Drivers |
|
| Opportunities |
|
| Restraint |
|
Want to Explore More, Connect to our Analyst – https://www.alliedmarketresearch.com/connect-to-analyst/1666
The vehicles and mucosal adjuvants segment held the largest market share in 2023
By type, the vehicles and mucosal adjuvants segment held the largest market share in 2023, accounting for more than half of the vaccine adjuvants market revenue and is expected to register the highest CAGR of 4.1% during the forecast period. This is attributed to their superior ability to enhance immune responses, improve antigen delivery, and support the development of effective mucosal vaccines. In addition, the increasing focus on innovative vaccine platforms and rise in prevalence of infectious diseases further drives the dominance of this segment.
The infectious diseases segment held the largest market share in 2023
By disease, the infectious diseases segment held the largest market share in 2023, accounting for more than four- fifths of the vaccine adjuvants market revenue and is expected to register the highest CAGR of 4.0% during the forecast period. This is attributed to increase in prevalence of infectious diseases globally, rise in demand for effective vaccines, and significant investments in vaccine research and development. In addition, the growing awareness of preventive healthcare and the expansion of immunization programs contribute to the segment growth.
The commercial segment held the largest market share in 2023
By application, the commercial segment held the largest market share in 2023, accounting for more than three-fourths of the vaccine adjuvants market revenue and is estimated to maintain its leadership status during the forecast period. This is attributed to rise in demand for large-scale vaccine production, rise in number of vaccination programs globally, and the expansion of vaccine distribution networks. In addition, the presence of key pharmaceutical companies and their ongoing efforts to innovate and enhance vaccine formulations are key factors driving the commercial segment dominance.
North America held the largest market share in 2023
North America dominated the market share in 2023, accounting for more than one-third of the vaccine adjuvants market revenue, owing to presence of leading vaccine manufacturers, robust healthcare infrastructure, and significant government support for immunization programs. In addition, high research and development investments, a well-established regulatory framework, and rise in awareness about the importance of vaccines further contribute to the region’s dominance in the market.
For Purchase Related Queries/Inquiry – https://www.alliedmarketresearch.com/purchase-enquiry/1666
Leading Market Players:
- Dynavax Technologies Corporation
- Croda International Plc
- Associated British Foods
The report provides a detailed analysis of these key players in the vaccine adjuvants market. These players have adopted strategies such as acquisition, expansion, product approvals, product launch and others to increase their market share and maintain dominant shares in different regions. The report is valuable in highlighting business performance, operating segments, product portfolio, and strategic moves of market players to highlight the competitive scenario.
Trending Reports in Healthcare Industry:
Point of Care Diagnostics Market – Global Opportunity Analysis and Industry Forecast, 2023-2032
Contraceptives Market – Global Opportunity Analysis and Industry Forecast, 2023-2032
Electrophysiology Market – Global Opportunity Analysis and Industry Forecast, 2023-2032
Orphan Drugs Market – Global Opportunity Analysis and Industry Forecast, 2023-2032
AVENUE- A Subscription-Based Library (Premium on-demand, subscription-based pricing model) Offered by Allied Market Research:
AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.
Get an access to the library of reports at any time from any device and anywhere. For more details, follow the link: https://www.alliedmarketresearch.com/library-access
About Allied Market Research:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact
David Correa
1209 Orange Street,
Corporation Trust Center,
Wilmington, New Castle,
Delaware 19801 USA.
Toll Free: +1-800-792-5285
Int’l: +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
Web: https://www.alliedmarketresearch.com
Follow Us on: LinkedIn Twitter
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
